BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Dcmp Deaminase

Below is an extended Dcmp Deaminase research listing. Click here to return to the Dcmp Deaminase main in depth entry.

Recent Publications on Dcmp Deaminase:

Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine.
1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine [HPMP-5-azaC],...
Direct Link
9th September, 2008
Rega Institute for Medical Research, Katholieke Universiteit Leuven,
Crystal structures of Streptococcus mutans 2'-deoxycytidylate deaminase and its complex with substrate analog and allosteric regulator dCTP x Mg2+.
2'-Deoxycytidylate deaminase [or deoxycytidine-5'-monophosphate (dCMP)...
Direct Link
25th March, 2008
Beijing Synchrotron Radiation Facility, Institute of High Energy Physics,
Involvement of deoxycytidylate deaminase in the response to S(n)1-type methylation DNA damage in budding yeast.
2''-Deoxycytidylate deaminase [or deoxycytidine-5''-monophosphate (dCMP)...
Direct Link
9th January, 2008
Molecular and Medical Genetics, Oregon Health & Science University,
An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.
PURPOSE: We examined the pattern of single-nucleotide polymorphisms (SNPs)...
Direct Link
21st September, 2007
Cancer Metastasis Research Center, Yonsei Cancer Center, Yonsei University
Chloroviruses encode a bifunctional dCMP-dCTP deaminase that produces two key intermediates in dTTP formation.
The chlorovirus PBCV-1, like many large double-stranded DNA-containing...
Direct Link
15th September, 2007
Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE
p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage.
Human fibroblasts in culture obtain deoxynucleotides by de novo...
Direct Link
11th July, 2007
Department of Biology, University of Padova, I-35131 Padova, Italy.
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.
PURPOSE: Gemcitabine is a nucleoside analogue with activity against solid...
Direct Link
9th December, 2006
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo
Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines.
OBJECTIVES: Significant variability in the efficacy and toxicity of an...
Direct Link
3rd November, 2006
Cancer Metastasis Research Center, Yonsei Cancer Center, Yonsei University
[Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation]
Deoxycytidine kinase (dCK) plays a central role in the deoxynucleoside...
Direct Link
12th May, 2005
Orvosi Vegytani, Molekularis Biologiai es Pathobiokemiai Intezet,
Three-dimensional structure of the R115E mutant of T4-bacteriophage 2'-deoxycytidylate deaminase.
2'-Deoxycytidylate deaminase (dCD) converts deoxycytidine 5'-monophosphate...
Direct Link
16th December, 2004
Wadsworth Center, New York State Department of Health, Albany, New York
An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines.
The mechanisms of resistance to the antimetabolite gemcitabine in...
Direct Link
28th July, 2004
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana,
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. 4th September, 2003
Department of Pathology, The Johns Hopkins University School of Medicine,
Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells. 2nd July, 2003
Department of Public Health and Microbiology, University of Torino, Via
Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase. 10th January, 2003
Department of Pharmacology, Yale University School of Medicine, New Haven,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional